Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  West Pharmaceutical Services Inc.    WST

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Sales1 4211 4001 5091 6051 7361 902
EBITDA273280315358413457
Operating profit (EBIT)183190224260303356
Pre-Tax Profit (EBT)------
Net income12795,6144204231270
P/E ratio30,446,344,435,331,727,0
EPS ( $ )1,751,301,912,743,053,58
Dividend per Share ( $ )0,410,460,500,530,570,62
Yield0,77%0,76%0,59%0,55%0,59%0,64%
Reference price ( $ )53.2460.2284.8396.4796.4796.47
Announcement Date02/19/2015
12:00pm
02/18/2016
12:00pm
02/16/2017
12:17pm
---
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 201420152016201720182019
Debt--25,6---
Finance---24,053,072,0
Operating income (EBITDA)273280315358413457
Leverage
(Debt/EBITDA)
--0,08x---
Capital Expenditure-132170160160160
Book Value Per Share (BVPS)-14,2 $15,3 $17,2 $18,8 $21,2 $
Cash Flow per Share2,51 $2,88 $2,93 $4,24 $4,58 $4,95 $
Announcement Date02/19/2015
12:00pm
02/18/2016
12:00pm
02/16/2017
12:17pm
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Advertisement
Financial Ratios

Size 2017e 2018e
Capitalization 7 096 M$ -
Entreprise Value (EV) 7 072 M$ 7 043 M$
Valuation 2017e 2018e
P/E ratio (Price / EPS) 35,3x 31,7x
Capitalization / Revenue 4,42x 4,09x
EV / Revenue 4,41x 4,06x
EV / EBITDA 19,8x 17,1x
Yield (DPS / Price) 0,55% 0,59%
Price to book (Price / BVPS) 5,62x 5,12x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 16,2% 17,5%
operating Leverage (Delta EBIT / Delta Sales) 2,54x 2,03x
Net Margin (Net Profit / Revenue) 12,7% 13,3%
ROA (Net Profit / Asset) 10,5% 11,5%
ROE (Net Profit / Equities) 16,2% 16,3%
Rate of Dividend 19,4% 18,7%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   9,97% 9,22%
Cash Flow / Sales 19,4% 19,4%
Capital Intensity (Assets / Sales) 1,21x 1,16x
Financial Leverage (Net Debt / EBITDA) -0,07x -0,13x
Price Earning Ratio Help 
The blue ligne is the average P/E ratio (without estimates)
EPS & Dividend